Daxor Corp.
Stock Exchange NYSE
EPS
$0.24
Market Cap
$31.66 M
Shares Outstanding
3.75 M
Public Float
783.23 K

Profile

Address
Empire State Building
New York New York 10118
United States
Employees -
Website http://www.daxor.com
Updated 07/08/2019
Daxor Corp. is a biotechnology company which develops and manufactures BVA-100 blood volume analyzer, an instrument that measures human blood volume. Its IDANT division provides autologous blood storage; and andrology services, such as semen analysis, sperm washing and general lab testing. The company was founded by Joseph Feldschuh in 1970 and is headquartered in New York, NY.

Financials

View All
Created with Highcharts 5.0.14Daxor Corp.Net Income. Fiscal year is January-December. All values USD Thousands.8 2188 2189769769 1469 1461 4551 4551 2391 23988588520132014201520162017201802.5k5k7.5k10k
Created with Highcharts 5.0.14Daxor Corp.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.5 0875 0872 8922 8925 9345 9346686681 4611 4611 3071 30720132014201520162017201801k2k3k4k5k6k7k

Michael R. Feldschuh
Chairman, President, CEO & EVP
Jonathan Feldschuh
Director & Chief Scientific Officer